Fact based stock research
Bio-Rad Laboratories (NYSE:BIO)

US0905722072

Bio-Rad Laboratories stock research in summary

Bio-Rad Laboratories shares have a market-typical stock price level. They are good value, are safely financed and show above average growth. We recommend evaluating whether the future of the company Bio-Rad Laboratories is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.

Latest Obermatt Ranks


Value Rank	62
Growth Rank	54
Safety Rank	61
Combined Rank	64

Country	USA
Industry	Life Sciences Tools & Services
Index	S&P 500
Size class	Large

January 8, 2021. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist

Filter Similar Stocks

Similar Top 10

Google: Bio-Rad Laboratories

News	Videos
Wikipedia about Bio-Rad Laboratories	Management
Employee Satisfaction	Customer Satisfaction

Research History: Bio-Rad Laboratories

RESEARCH HISTORY	2018	2019	2020	2021
VALUE
VALUE	71	58	62	62
GROWTH
GROWTH	38	53	54	54
SAFETY
SAFETY	94	94	61	61
COMBINED
COMBINED	88	82	64	64

Last update of Combined Rank: 8-Jan-2021. Financial reporting date used for calculating ranks: 30-Jun-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better Bio-Rad Laboratories is in the corresponding investment strategy.

Value Metrics in Detail

VALUE METRICS	2018	2019	2020	2021
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)	59	42	46	46
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)	100	98	100	100
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)	62	56	63	63
DIVIDEND YIELD
DIVIDEND YIELD	1	1	1	1
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE	71	58	62	62

Last update of Value Rank: 8-Jan-2021. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Bio-Rad Laboratories; except for dividend yield where the rank is higher, the higher the yield.

Growth Metrics in Detail

GROWTH METRICS	2018	2019	2020	2021
REVENUE GROWTH
REVENUE GROWTH	13	25	37	37
PROFIT GROWTH
PROFIT GROWTH	33	47	43	43
STOCK RETURNS
STOCK RETURNS	86	69	70	70
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH	38	53	54	54

Last update of Growth Rank: 30-Jun-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Bio-Rad Laboratories.

Safety Metrics in Detail

SAFETY METRICS	2018	2019	2020	2021
LEVERAGE
LEVERAGE	56	50	35	35
REFINANCING
REFINANCING	74	62	71	71
LIQUIDITY
LIQUIDITY	81	94	68	68
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY	94	94	61	61

Last update of Safety Rank: 1-Jan-2021. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Bio-Rad Laboratories and the more cash is available to service its debt.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Bio-Rad Laboratories from January 8, 2021.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.